Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Acta Pharmacol Sin. 2010 Apr 12;31(5):560–569. doi: 10.1038/aps.2010.31

Table 1.

In vivo hemodynamic characterization of C57, db/db, TMZ-low, and TMZ-high mice. Data shown represent the mean±SEM for control (C57, n=8), diabetic (db/db, n=10), low-dose TMZ-treated (TMZ-low, n=6) and high-dose TMZ-treated (TMZ-high, n=6) mice.

C57 db/db TMZ-low TMZ-high
Heart rate (beat/min) 300±8.05 356±21.7b 283±16.2e 295±8.12e
Maximum volume (µL) 18.1±0.39 14.3±0.22b 14.9±0.42b 16.7±0.65be
LVESP (mmHg) 94.6±2.33 129±2.42b 115±7.44be 112±3.42be
LVEDP (mmHg) 5.76±0.32 124±3.31b 110±7.10be 108±4.20be
LVEDP (mmHg) 5.76±0.32 10.4±0.92b 7.63±0.67e 7.89±0.96e
Stroke volume (µL) 3.86±0.14 3.00±0.15b 3.35±0.21 3.98±0.11e
Cardiac output (µL/min) 735±41.9 559±30.0b 775±63.0e 739±24.0e
dp/dtmax (mmHg/s) 3190±278 7440±434b 6730±488b 6270±525b
dp/dtmin (mmHg/s) −2860±101 −4040±324b −4160±181b −3990±364b

Hemodynamic parameters were measured with a cardiac catheter tip manometer advanced from the right carotid artery via the aortic arch into the left ventricle. LVESP, LV end systolic pressure; LVEDP, LV end diastolic pressure; dp/dtmax and dp/dtmin, positive and negative first derivative of LV contraction and relaxation, respectively.

b

P<0.05 compared to the C57 mice group.

e

P<0.05 compared to the db/db mice group.